Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_335a7fa4cae44e51a9f4bf828c3c45ca |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-82 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6845 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2022-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64ca732d1c503bb204e91937c8b05938 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9fd9b12877ff311c43f11688f5c9151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ba1b7162fe0ddd3c341af80d738e756 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c20eca93275097b383581e7e6bef8fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e3ecd95f547e18e582658196321c7e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f8c0ef31ef0e64f9bb39ae742e2e7a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_264dffbb6b75923c30ba1f29926b2ad4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc13fde85845b50dd9cbdd9076ab6fcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4133cf4c30690d9cdcb90616a1f8fd6 |
publicationDate |
2022-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20220010051-A |
titleOfInvention |
Method of Response Prediction For BCL2 family Protein Targeting Drug |
abstract |
Provided are a method for predicting responsiveness to a drug targeting a BCL2 family protein, and a method for selecting a target suitable for treatment with a drug targeting a BCL2 family protein. |
priorityDate |
2019-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |